Preferred Label : asunaprevir;
MeSH note : an NS3 protease inhibitor against hepatitis C virus;
CISMeF synonym : BMS-650032;
MeSH hyponym : BMS 650032;
MeSH CAS label : cyclopropanecarboxamide, N-((1,1-dimethylethoxy)carbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenyl-,
(1R,2S)-;
Is substance : O;
UNII : S9X0KRJ00S;
Origin ID : C571889;
UMLS CUI : C3491974;
ATC code(s)
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
SUNVEPRA - Summary Basis of Decision (SBD)
Asunaprevir, 100 mg , capsule, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00297
2016
false
false
false
false
Canada
French
English
summary of product characteristics
administration, oral
asunaprevir
asunaprevir
NS3 protein, hepatitis C virus
risk assessment
drug evaluation
drug approval
canada
adult
hepatitis C, chronic
drug therapy, combination
Hepatitis C virus genotype 4 (organism)
Hepatitis C virus genotype 1 (organism)
Cirrhosis of liver due to chronic hepatitis C (disorder)
antiviral agents
antiviral agents
protease inhibitors
protease inhibitors
treatment outcome
asunaprevir
isoquinolines
sulfonamides
isoquinolines
sulfonamides
viral nonstructural proteins
---